Class 5 and beyond: The impact of new treatment technologies on pharmaceutical trademarks

Sudipta Rao
Head of Legal Brand Protection, Global Oncology
Maury M. Tepper III
Founder and Principal
Tepper & Eyster, PLLC

Pharmaceutical companies are advancing the science of treatment beyond traditional medications. New technologies—from radiopharmaceuticals to immunotherapy to mobile apps—are redefining the industry. For IP professionals, these revolutionary advances demand new strategies for clearing and protecting pharma trademarks that go beyond the traditional Class 5 model. In this webinar, two legal professionals explore this fascinating development from both the law firm and in-house counsel perspective, offering best practices for maximizing trademark protection while minimizing the risk of rejection.

We will be covering the following topics:

  • Unique aspects of pharmaceutical trademark clearance
  • New technologies that are changing the pharmaceutical landscape
  • Assessing situations when therapies embrace multiple classes
  • New trademark enforcement strategies
  • How COVID-19 is affecting trademark filing patterns